Balaxi Pharmaceuticals Market Cap

Balaxi Pharmaceuticals has a market cap or net worth of 2.64 billion as of June 6, 2025. Its market cap has decreased by -60.32% in one year.

Market Cap

2.64B

Enterprise Value

2.78B

Revenue

2.93B

Ranking

n/a

PE Ratio

11.44

Stock Price

52.00

Market Cap Chart

Since December 1, 2015, Balaxi Pharmaceuticals's market cap has increased from 41.50M to 2.64B, an increase of 6,273.10%. That is a compound annual growth rate of 54.71%.

Market Cap History

Date	Market Cap	% Change
Jun 6, 2025	2.64B	-28.16%
Dec 31, 2024	3.68B	-16.38%
Dec 29, 2023	4.40B	-27.68%
Dec 30, 2022	6.09B	18.63%
Dec 31, 2021	5.13B	-21.05%
Dec 31, 2020	6.50B	700.37%
Dec 31, 2019	Pro	Pro
Dec 19, 2017	Pro	Pro
Dec 8, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	3,994.65B
Divi's Laboratories	1,756.87B
Cipla	1,188.77B
Apollo Hospitals Enterprise	988.66B
Mankind Pharma	973.57B
Zydus Lifesciences	961.66B
Aurobindo Pharma	673.44B
Alkem Laboratories	582.10B

Market Cap Rankings